AMPH
Amphastar Pharmaceuticals, Inc.
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Buy
+43/100
Last price
25.91
▲ 0.54 (2.13%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
25.55
Prev close
25.37
Day high
26.08
Day low
25.03
Volume
469.14K
Market cap
$1.10B
P/E (TTM)
15.33
52W range
16.65 – 29.52
Day trading desk
Gap from prior close
+0.71%
Prior close 25.37
VWAP
25.80
+0.43% from price
Relative volume
1.69×
Unusually busy
Session range
13.39%
23.00 – 26.08
Position in range
94%
Near session high
ATR (14D)
1.02
3.95% of price
Prior day high
25.70
PDH
Prior day low
25.17
PDL
Bid / ask spread
—
Quote not published
Session volume
789.08K
Avg 467.31K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-2.89%
-4.8%
1M
+11.78%
+10.6%
3M
+37.24%
+32.7%
6M
+25.90%
+7.7%
YTD
-3.25%
-17.5%
1Y
-3.14%
-19.6%
3Y
-43.66%
-125.9%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on AMPH open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
+39.82K
Net buying
Buy transactions
10
73.30K shares
Sell transactions
5
33.48K shares
Net transactions
+15
Buys less sells
Sell : buy shares
0.5 : 1
Mixed
Insider-held shares
13.11M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Sep 21, 26 | PETERS WILLIAM J Chief Financial Officer |
SELL | 4.14K | $103.47K | Direct |
| Sep 16, 26 | ZHOU RONG Officer |
CONVERSION | 10.00K | $133.50K | Direct |
| Sep 16, 26 | ZHOU RONG Officer |
SELL | 10.00K | $239.40K | Direct |
| Sep 2, 26 | ZHOU RONG Officer |
SELL | 3.19K | $75.31K | Direct |
| Aug 11, 26 | PRINS RICHARD K Director |
SELL | 7.97K | $161.85K | Direct |
| Aug 7, 26 | PETERS WILLIAM J Chief Financial Officer |
CONVERSION | 5.05K | $100.00K | Direct |
| Aug 7, 26 | PETERS WILLIAM J Chief Financial Officer |
SELL | 8.18K | $183.89K | Direct |
| Jul 9, 26 | PIERCE ANTHONY T Director |
STOCK | 7.89K | $0 | Direct |
| Jun 1, 26 | ZASLOFF MICHAEL A Director |
STOCK | 8.14K | $0 | Direct |
| Jun 1, 26 | PRINS RICHARD K Director |
STOCK | 8.14K | $0 | Direct |
| Jun 1, 26 | LEE HOWARD S Director |
STOCK | 8.14K | $0 | Direct |
| Jun 1, 26 | GERST DIANE G. Director |
STOCK | 8.14K | $0 | Direct |
| Jun 1, 26 | DEFLIN GAYLE Director |
STOCK | 8.14K | $0 | Direct |
| Jun 1, 26 | GAUGH DAVID RUSSELL Director |
STOCK | 8.14K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
DEFLIN GAYLE |
Director | 19.06K | Stock Award(Grant) |
GERST DIANE G. |
Director | 31.90K | Stock Award(Grant) |
LEE HOWARD S |
Director | 159.35K | Stock Award(Grant) |
LIAWATIDEWI YAKOB |
Officer and Director | 125.38K | Stock Award(Grant) |
PETERS WILLIAM J |
Chief Financial Officer | 168.71K | Sale |
PETERSEN FLOYD F |
Director | 71.37K | Sale |
PRINS RICHARD K |
Director | 29.63K | Sale |
ZASLOFF MICHAEL A |
Director | 37.67K | Stock Award(Grant) |
ZHANG JACK YONGFENG |
Chief Executive Officer | — | Stock Award(Grant) |
ZHOU RONG |
Officer | 273.87K | Conversion of Exercise of derivative security |
Fundamentals
Market cap$1.10B
Enterprise value$1.50B
Revenue (TTM)$730.02M
Gross profit$348.11M
EBITDA$194.51M
Net income$78.55M
EPS (TTM)$1.69
Free cash flow$230.10M
Total cash$290.12M
Total debt$688.32M
Book value / share$18.06
Shares outstanding42.54M
Float31.29M
Short % of float25.59%
Dividend yield0.00%
Beta (5Y)0.90
Valuation & profitability ratios
Trailing P/E15.33
Forward P/E8.14
PEG ratio—
Price / sales—
Price / book1.43
EV / revenue2.06
EV / EBITDA7.71
Gross margin47.69%
Operating margin21.60%
Profit margin10.76%
Return on equity10.30%
Return on assets5.11%
Debt / equity89.61
Current ratio2.40
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $719.89M | $731.97M | $644.39M | $498.99M | -1.7% |
| Operating revenue | $719.89M | $712.81M | $593.24M | $498.99M | +1.0% |
| Cost of revenue | $363.83M | $358.11M | $293.27M | $250.13M | +1.6% |
| Gross profit | $356.06M | $373.86M | $351.12M | $248.86M | -4.8% |
| Research & development | $85.84M | $73.91M | $73.74M | $74.77M | +16.1% |
| Selling, general & admin | $129.81M | $94.52M | $80.39M | $66.59M | +37.3% |
| Total operating expense | $215.65M | $168.44M | $154.13M | $141.36M | +28.0% |
| Operating income | $140.40M | $205.42M | $196.99M | $107.50M | -31.7% |
| Net interest income | -$16.80M | -$19.73M | -$21.70M | -$525.00K | +14.8% |
| Pre-tax income | $123.62M | $189.76M | $171.36M | $116.04M | -34.9% |
| Tax provision | $25.53M | $29.67M | $31.83M | $23.48M | -14.0% |
| Net income | $98.09M | $159.52M | $137.54M | $91.39M | -38.5% |
| Net income to common | $98.09M | $159.52M | $137.54M | $91.39M | -38.5% |
| Basic EPS | 2.10 | 3.29 | 2.85 | 1.88 | -36.2% |
| Diluted EPS | 2.03 | 3.06 | 2.60 | 1.74 | -33.7% |
| EBIT | $149.10M | $220.11M | $198.52M | $117.89M | -32.3% |
| EBITDA | $212.31M | $277.31M | $240.29M | $146.16M | -23.4% |
| Basic shares | 46.74M | 48.43M | 48.27M | 48.55M | -3.5% |
| Diluted shares | 48.22M | 52.06M | 53.00M | 52.43M | -7.4% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $170.18M | $151.61M | $144.30M | $156.10M | +12.2% |
| Cash & short-term investments | $282.81M | $221.65M | $256.81M | $175.76M | +27.6% |
| Accounts receivable | $143.56M | $136.29M | $114.94M | $88.80M | +5.3% |
| Inventory | $176.89M | $153.74M | $105.83M | $103.58M | +15.1% |
| Total current assets | $636.02M | $534.07M | $489.60M | $378.32M | +19.1% |
| Property, plant & equipment | $353.72M | $344.63M | $315.64M | $264.57M | +2.6% |
| Goodwill & intangibles | $565.97M | $590.66M | $613.29M | $37.30M | -4.2% |
| Total assets | $1.63B | $1.58B | $1.51B | $741.99M | +3.3% |
| Total current liabilities | $158.16M | $173.76M | $225.41M | $94.86M | -9.0% |
| Current debt | $1.64M | $234.00K | $436.00K | $3.05M | +601.3% |
| Long-term debt | $608.75M | $601.63M | $589.58M | $72.84M | +1.2% |
| Total debt | $656.00M | $650.55M | $623.64M | $102.58M | +0.8% |
| Total liabilities | $840.49M | $845.17M | $873.49M | $213.33M | -0.6% |
| Retained earnings | $666.88M | $568.79M | $409.27M | $271.72M | +17.2% |
| Shareholder equity | $788.80M | $732.30M | $639.42M | $528.66M | +7.7% |
| Working capital | $477.86M | $360.31M | $264.19M | $283.46M | +32.6% |
| Net tangible assets | $222.84M | $141.64M | $26.13M | $491.36M | +57.3% |
| Shares issued | 61.78M | 60.85M | 59.39M | 58.11M | +1.5% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $98.09M | $159.52M | $137.54M | $91.39M | -38.5% |
| Depreciation & amortisation | $63.20M | $57.20M | $41.78M | $28.27M | +10.5% |
| Stock-based compensation | $27.28M | $24.37M | $20.24M | $17.86M | +11.9% |
| Change in working capital | -$65.97M | -$14.55M | -$24.21M | -$32.18M | -353.5% |
| Operating cash flow | $156.12M | $213.39M | $183.50M | $89.18M | -26.8% |
| Capital expenditure | -$37.13M | -$41.04M | -$38.17M | -$24.03M | +9.5% |
| Investing cash flow | -$70.33M | -$124.93M | -$649.12M | -$32.78M | +43.7% |
| Share buybacks | -$75.59M | -$85.46M | -$58.14M | -$39.91M | +11.6% |
| Financing cash flow | -$67.42M | -$80.95M | $454.09M | -$26.44M | +16.7% |
| Free cash flow | $118.98M | $172.34M | $145.34M | $65.15M | -31.0% |
| End cash position | $170.41M | $151.84M | $144.53M | $156.33M | +12.2% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $183.90M | $171.17M | $183.10M | $191.84M | $174.41M | +7.4% |
| Operating revenue | $183.90M | $171.17M | $183.10M | $191.84M | $174.41M | +7.4% |
| Cost of revenue | $90.43M | $100.85M | $97.44M | $93.19M | $87.92M | -10.3% |
| Gross profit | $93.47M | $70.32M | $85.67M | $98.65M | $86.49M | +32.9% |
| Research & development | $22.16M | $26.74M | $23.31M | $22.35M | $20.08M | -17.1% |
| Selling, general & admin | $31.58M | $29.95M | $26.75M | $50.97M | $24.23M | +5.4% |
| Total operating expense | $53.74M | $56.69M | $50.06M | $73.33M | $44.31M | -5.2% |
| Operating income | $39.73M | $13.63M | $35.61M | $25.32M | $42.18M | +191.5% |
| Net interest income | -$4.37M | -$4.15M | -$4.21M | -$4.04M | -$4.36M | -5.3% |
| Pre-tax income | $38.54M | $10.05M | $31.91M | $21.51M | $39.34M | +283.4% |
| Tax provision | $8.20M | $3.63M | $7.49M | $4.16M | $8.30M | +125.7% |
| Net income | $30.35M | $6.42M | $24.43M | $17.35M | $31.03M | +372.7% |
| Net income to common | $30.35M | $6.42M | $24.43M | $17.35M | $31.03M | +372.7% |
| Basic EPS | 0.69 | 0.14 | 0.53 | 0.38 | 0.66 | +392.9% |
| Diluted EPS | 0.67 | 0.14 | 0.51 | 0.37 | 0.64 | +378.6% |
| EBIT | $45.20M | $16.61M | $38.54M | $27.80M | $45.62M | +172.2% |
| EBITDA | $61.66M | $33.10M | $54.53M | $43.56M | $61.85M | +86.3% |
| Basic shares | 43.64M | 45.32M | 45.91M | 46.47M | 46.95M | -3.7% |
| Diluted shares | 44.23M | 46.46M | 47.16M | 47.68M | 48.13M | -4.8% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $223.61M | $170.94M | $170.18M | $216.26M | $187.69M | +30.8% |
| Cash & short-term investments | $290.12M | $291.95M | $282.81M | $276.21M | $231.75M | -0.6% |
| Accounts receivable | $144.86M | $147.85M | $143.56M | $146.81M | $132.98M | -2.0% |
| Inventory | $179.91M | $170.19M | $176.89M | $185.93M | $191.73M | +5.7% |
| Total current assets | $630.95M | $633.68M | $636.02M | $639.47M | $580.83M | -0.4% |
| Property, plant & equipment | $389.13M | $378.91M | $353.72M | $353.52M | $354.73M | +2.7% |
| Goodwill & intangibles | $647.83M | $559.62M | $565.97M | $572.24M | $578.50M | +15.8% |
| Total assets | $1.74B | $1.65B | $1.63B | $1.67B | $1.62B | +5.8% |
| Total current liabilities | $263.20M | $164.48M | $158.16M | $205.23M | $176.41M | +60.0% |
| Current debt | $2.49M | $1.67M | $1.64M | $923.00K | $927.00K | +48.9% |
| Long-term debt | $609.56M | $609.80M | $608.75M | $608.58M | $607.73M | -0.0% |
| Total debt | $688.32M | $686.38M | $656.00M | $656.77M | $655.50M | +0.3% |
| Total liabilities | $975.61M | $874.77M | $840.49M | $889.48M | $857.85M | +11.5% |
| Retained earnings | $703.65M | $673.30M | $666.88M | $642.45M | $625.10M | +4.5% |
| Shareholder equity | $768.16M | $773.39M | $788.80M | $776.75M | $757.48M | -0.7% |
| Working capital | $367.75M | $469.20M | $477.86M | $434.24M | $404.42M | -21.6% |
| Net tangible assets | $120.32M | $213.77M | $222.84M | $204.51M | $178.98M | -43.7% |
| Shares issued | 42.53M | 62.13M | 61.78M | 61.68M | 61.65M | -31.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $30.35M | $6.42M | $24.43M | $17.35M | $31.03M | +372.7% |
| Depreciation & amortisation | $16.46M | $16.49M | $15.99M | $15.77M | $16.24M | -0.2% |
| Stock-based compensation | $7.09M | $9.27M | $6.21M | $6.30M | $6.38M | -23.5% |
| Change in working capital | -$2.58M | $15.30M | -$42.73M | $12.00M | -$18.52M | -116.9% |
| Operating cash flow | $51.32M | $47.84M | $32.86M | $52.58M | $35.59M | +7.3% |
| Capital expenditure | -$8.59M | -$9.51M | -$8.27M | -$5.35M | -$12.81M | +9.6% |
| Investing cash flow | $44.87M | -$16.73M | -$60.57M | -$19.62M | -$625.00K | +368.2% |
| Share buybacks | -$45.21M | -$29.49M | -$20.52M | -$4.85M | -$39.22M | -53.3% |
| Financing cash flow | -$43.53M | -$30.21M | -$18.37M | -$4.35M | -$30.20M | -44.1% |
| Free cash flow | $42.73M | $38.33M | $24.59M | $47.23M | $22.78M | +11.5% |
| End cash position | $223.85M | $171.17M | $170.41M | $216.50M | $187.92M | +30.8% |
Options analytics
Put / call volume
0.02
Call-heavy session
Put / call open interest
—
Positioning, not flow
Max pain
17.50
-32.5% from spot
ATM implied vol
0.0%
Nearest strike to spot
Skew (10% OTM)
0.0%
Calls bid over puts
Call volume
49
Contracts, this expiry
Put volume
1
Contracts, this expiry
Heaviest call OI
20.00
0 contracts
Heaviest put OI
17.50
0 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.61 | 0.91 | +48.3% |
| Mar 2026 | 0.71 | 0.42 | -40.5% |
| Dec 2025 | 0.92 | 0.73 | -20.5% |
| Sep 2025 | 0.83 | 0.93 | +12.7% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.86 | 7 | $197.84M | +3.2% |
| Next quarter | 0.69 | 1 | $194.77M | +6.4% |
| Current year | 2.97 | 7 | $747.75M | +3.9% |
| Next year | 2.64 | 1 | $784.41M | +4.9% |
Analyst targets & ownership
Mean target$22.50
High target$30.00
Low target$20.00
Implied upside-13.16%
Analyst count6
ConsensusNONE
Strong buy / Buy0 / 0
Hold6
Sell / Strong sell0 / 1
Held by insiders30.81%
Held by institutions68.50%
Institutions holding303
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
25.93
-0.08% from price
SMA 20
24.87
+4.18% from price
SMA 50
22.74
+13.94% from price
SMA 100
21.00
+23.40% from price
SMA 200
22.35
+15.93% from price
EMA 12
25.44
+1.86% from price
EMA 26
24.51
+5.72% from price
EMA 50
23.29
+11.24% from price
RSI (14)
62.5
Neutral
MACD (12,26,9)
0.93
Hist -0.08
ATR (14)
1.02
3.95% of price
Realised vol 30D
32.7%
Annualised
Bollinger upper
27.26
20, 2σ
Bollinger lower
22.48
20, 2σ
50 / 200 cross
Golden
22.74 vs 22.35
Trend bias
Above 200
+15.93%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.57
Less volatile than market
Correlation to SPY
0.14
Largely independent
Realised vol 30D
32.7%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-42.6%
Peak to trough
Max drawdown 5Y
-74.0%
Peak to trough
ATR 14
1.02
3.95% of price
Beta (reported)
0.90
5Y monthly, from filing
Short interest
Shares short
4.99M
Prior 5.39M
Change vs prior
-7.3%
Shorts covering
% of float
25.59%
Heavily shorted
% of shares out
11.74%
Against total outstanding
Days to cover
12.5
Crowded exit
Float
31.29M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 18, 26 | Barclays | MAINTAINED | Equal-Weight | Equal-Weight |
| Aug 7, 26 | Piper Sandler | MAINTAINED | Neutral | Neutral |
| Aug 7, 26 | Wells Fargo | MAINTAINED | Equal-Weight | Equal-Weight |
| Jun 29, 26 | B of A Securities | DOWNGRADE | Neutral | Underperform |
| Jun 3, 26 | Barclays | MAINTAINED | Equal-Weight | Equal-Weight |
| May 14, 26 | Wells Fargo | DOWNGRADE | Overweight | Equal-Weight |
| May 11, 26 | Piper Sandler | MAINTAINED | Neutral | Neutral |
| May 8, 26 | Needham | DOWNGRADE | Buy | Hold |
| Apr 21, 26 | Jefferies | DOWNGRADE | Buy | Hold |
| Apr 8, 26 | Barclays | MAINTAINED | Equal-Weight | Equal-Weight |
| Feb 27, 26 | Wells Fargo | MAINTAINED | Overweight | Overweight |
| Feb 27, 26 | Needham | MAINTAINED | Buy | Buy |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split—
Split date—
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-08-06
Corporate Changes & Voting Matters
8-K · 2026-07-13
Corporate Changes & Voting Matters
8-K · 2026-07-08
Corporate Changes & Voting Matters
8-K · 2026-06-03
Corporate Changes & Voting Matters
8-K · 2026-05-07
Proxy Statements
DEF 14A · 2026-04-13
Corporate Changes & Voting Matters
8-K · 2026-03-16
Corporate Changes & Voting Matters
8-K · 2026-03-06
Headlines
Should Value Investors Buy Amphastar Pharmaceuticals (AMPH) Stock?
Zacks · 19h ago
3 Stocks Under $50 We Think Twice About
StockStory · 6d ago
3 Reasons to Avoid AMPH and 1 Stock to Buy Instead
StockStory · 13d ago
3 Russell 2000 Stocks We Find Risky
StockStory · 16d ago
3 Small-Cap Stocks with Warning Signs
StockStory · 18d ago
Amphastar Pharmaceuticals (NASDAQ:AMPH): Strongest Q2 Results from the Generic Pharmaceuticals Group
StockStory · 20d ago
Amphastar Pharmaceuticals (AMPH) Rebounds In Focus, Is It Slightly Overvalued?
Simply Wall St. · 30d ago
Amphastar Pharmaceuticals (AMPH) Stock Looks Cheap With Earnings Doing The Heavy Lifting
Simply Wall St. · 32d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.